Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 74

Sort by

Sort Order Select

Journal Articles

Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Blood (2024) 144 (Supplement 1): 512.

https://doi.org/10.1182/blood-2024-205779

Published: 2024

Journal Articles

ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

Blood (2024) 144 (Supplement 1): 409.

https://doi.org/10.1182/blood-2024-200867

Published: 2024

Journal Articles

The Utility of Maternal Placental Growth Factor (PlGF) for Prediction of Pre-Eclampsia in Pregnancies Complicated By Sickle Cell Disease

Evangelia Vlachodimitropoulou, Tharshini Balasubramanian, Nadine Shehata, Richard Ward, Kevin H.M. Kuo, John Kingdom, A. Kinga Malinowski

Blood (2024) 144 (Supplement 1): 1118.

https://doi.org/10.1182/blood-2024-206330

Published: 2024

Journal Articles

Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease

Akshay Sharma, Haydar Frangoul, Franco Locatelli, Kevin H.M. Kuo, Monica Bhatia, Markus Y Mapara, Michael J. Eckrich, Suzan Imren, Nanxin Li, Jaime Rubin, Siyu Zhang, Tina Liu, William Hobbs, Stephan A. Grupp

Blood (2024) 144 (Supplement 1): 7453.

https://doi.org/10.1182/blood-2024-204112

Published: 2024

Journal Articles

Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia

Blood (2024) 144 (Supplement 1): 7454.

https://doi.org/10.1182/blood-2024-204115

Published: 2024

Journal Articles

Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II - Results from the 8-Week Dose-Escalation Period

Thomas Doeven, Eduard J. Van Beers, Richard van Wijk, Evelyn Groot, Joline L Saes, Jennifer Bos, Jonathan R.A. De Wilde, Minke A.E. Rab, Selma K Bendtsen, Jesper Petersen, Niels G Vejlstrup, Jens Helby, Adeline Gladieux, Fatiha Chermat, Pierre Fenaux, Kevin H.M. Kuo, Andreas Glenthøj

Blood (2024) 144 (Supplement 1): 3831.

https://doi.org/10.1182/blood-2024-198359

Published: 2024

Journal Articles

Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 4954.

https://doi.org/10.1182/blood-2024-204001

Published: 2024

Journal Articles

Improvement of Iron Overload Parameters in Patients with Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Data from the Phase 3b Long-Term Rollover Study Following the BELIEVE Trial

John B. Porter, Maria Domenica Cappellini, Kevin H.M. Kuo, Maria Dimopoulou, Marta Reverte, Loyse Felber Medlin, Shweta Sharma, Kefeng Wang, Jennie Zhang, Ali T. Taher

Blood (2024) 144 (Supplement 1): 2475.

https://doi.org/10.1182/blood-2024-200157

Published: 2024

Journal Articles

Evaluating the Effect of Hydroxyurea on Fertility in Individuals Identifying As Women

Vanessa Shao, Claire Jones, A. Kinga Malinowski, Kevin H.M. Kuo, Richard Ward, John Chinawaeze Aneke, Andrew Binding, Nadine Shehata

Blood (2024) 144 (Supplement 1): 2509.

https://doi.org/10.1182/blood-2024-203393

Published: 2024

Journal Articles

Clinical Monitoring Practices Among Adult Patients with Pyruvate Kinase Deficiency Who Have Never Been Transfused

Stefan W Eber, Andreas Glenthøj, Bertil Glader, Dagmar Pospisilova, Eduard J. van Beers, Rachael F. Grace, Joan-Lluis Vives Corrons, Hitoshi Kanno, Kevin H.M. Kuo, Paola Bianchi, Audra Boscoe, Bryan McGee, Yan Yan, Junlong Li, Janet H. Ford, Carl Lander

Blood (2024) 144 (Supplement 1): 3696.

https://doi.org/10.1182/blood-2024-200739

Published: 2024

Journal Articles

Validitation of the Rowland Universal Dementia Assessment Scale (RUDAS) for the Detection of Cognitive Impairment Among Adults with Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 5068.

https://doi.org/10.1182/blood-2024-209963

Published: 2024

Journal Articles

Risk Factors for Postnatal Complications in People with Sickle Cell Disease: A Preliminary Analysis

Joanna Loh, A. Kinga Malinowski, Richard Ward, Nadine Shehata, Kevin H.M. Kuo, Ilinca Georgescu

Blood (2023) 142 (Supplement 1): 3904.

https://doi.org/10.1182/blood-2023-190328

Published: 2023

Journal Articles

Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)

Andreas Glenthoej, Eduard J. Van Beers, Richard van Wijk, Minke A.E. Rab, Evelyn Groot, Niels G Vejlstrup, Selma K Bendtsen, Nina Toft, Jesper Petersen, Jens Helby, Fatiha Chermat, Pierre Fenaux, Kevin H.M. Kuo

Blood (2023) 142 (Supplement 1): 1085.

https://doi.org/10.1182/blood-2023-173147

Published: 2023

Journal Articles

Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling Parameters

Kevin H.M. Kuo, Sylvia Titi Singer, Gershwin Theophilus Blyden, Lanetta Bronté-Hall, Aidan Faller, Abdullah Kutlar, Frans A. Kuypers, Aliya U. Zaidi, Patrick C. Hines, Niren Patel, Sandra Larkin, Hanny Al-Samkari, Sujit Sheth, Seyed Mehdi Nouraie, Susan Perrine

Blood (2023) 142 (Supplement 1): 1148.

https://doi.org/10.1182/blood-2023-184627

Published: 2023

Journal Articles

Improvements in Markers of Hemolysis and Liver Iron Concentration in Mitapivat-Treated Adult Patients with a Delayed Hemoglobin Response

Eduard J. Van Beers, Bryan McGee, Rengyi Xu, Melissa Dibacco, Kevin H.M. Kuo, Hanny Al-Samkari

Blood (2023) 142 (Supplement 1): 5226.

https://doi.org/10.1182/blood-2023-186533

Published: 2023

Journal Articles

Burden of Illness of Alpha- and Beta-Thalassemia: A Qualitative Study

Sujit Sheth, Alexander K Glaros, Mona Martin, Cristina Abel, William R Lenderking, Susan Morris, Keely S Gilroy, Kevin H.M. Kuo

Blood (2023) 142 (Supplement 1): 7329.

https://doi.org/10.1182/blood-2023-189367

Published: 2023

Journal Articles

Risk Factors for Thrombosis in Pregnant People with Sickle Cell Disease: A Multinational Study.

Sacha Belinda Mapombo Choupa, Amy Luo, Clare Zarka, A. Kinga Malinowski, Kevin H.M. Kuo, Nadine Shehata, Sophie M. Lanzkron, Lydia H Pecker

Blood (2023) 142 (Supplement 1): 807.

https://doi.org/10.1182/blood-2023-182839

Published: 2023

Journal Articles

Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study

Khaled M Musallam, Ali T Taher, Antonis Kattamis, Maria Domenica Cappellini, Jennifer Lord-Bessen, Mrudula Glassberg, Christopher Pelligra, Shien Guo, Loyse Felber Medlin, Luciana Moro Bueno, Kevin H.M. Kuo

Blood (2023) 142 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2023-173366

Published: 2023

Journal Articles

Comparison of Alloimmunization in Pregnant People with Sickle Cell Disease Receiving Chronic Versus on-Demand Transfusions: A Multinational Study

Clare Zarka, Amy Luo, Sacha Belinda Mapombo Choupa, A. Kinga Malinowski, Kevin H.M. Kuo, Nadine Shehata, Sophie Lanzkron, Lydia H Pecker

Blood (2023) 142 (Supplement 1): 927.

https://doi.org/10.1182/blood-2023-178410

Published: 2023

Journal Articles

Clocking the Processes and Challenges of Urgent Red Blood Cell Exchange for Acute Complications of Sickle Cell Disease

Kristine Matusiak, Christine M. Cserti-Gazdewich, Nadine Shehata, Kevin H.M. Kuo, Justin Kim, David Barth, Christopher J. Patriquin

Blood (2023) 142 (Supplement 1): 2308.

https://doi.org/10.1182/blood-2023-184941

Published: 2023

NARROW

Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

ENERGIZE-T: A Global, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia

The Utility of Maternal Placental Growth Factor (PlGF) for Prediction of Pre-Eclampsia in Pregnancies Complicated By Sickle Cell Disease

Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease

Health-Related Quality-of-Life Improvements after Exagamglogene Autotemcel in Patients with Transfusion-Dependent Beta-Thalassemia

Satisfy: A Eurobloodnet Multicenter, Single-Arm Phase 2 Trial of Mitapivat in Adult Patients with Erythrocyte Membranopathies and Congenital Dyserythropoietic Anemia Type II - Results from the 8-Week Dose-Escalation Period

Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease

Improvement of Iron Overload Parameters in Patients with Transfusion-Dependent β-Thalassemia Treated with Luspatercept: Data from the Phase 3b Long-Term Rollover Study Following the BELIEVE Trial

Evaluating the Effect of Hydroxyurea on Fertility in Individuals Identifying As Women

Clinical Monitoring Practices Among Adult Patients with Pyruvate Kinase Deficiency Who Have Never Been Transfused

Validitation of the Rowland Universal Dementia Assessment Scale (RUDAS) for the Detection of Cognitive Impairment Among Adults with Sickle Cell Disease

Risk Factors for Postnatal Complications in People with Sickle Cell Disease: A Preliminary Analysis

Safety and Efficacy of Mitapivat in Adult Patients with Erythrocyte Membranopathies (SATISFY)

Initial Results in a Phase 1b Trial of PB-04 in Sickle Cell Disease Demonstrate Fetal Hemoglobin Induction, Additive Activity with Hydroxyurea, and Improved Red Blood Cell Sickling Parameters

Improvements in Markers of Hemolysis and Liver Iron Concentration in Mitapivat-Treated Adult Patients with a Delayed Hemoglobin Response

Burden of Illness of Alpha- and Beta-Thalassemia: A Qualitative Study

Risk Factors for Thrombosis in Pregnant People with Sickle Cell Disease: A Multinational Study.

Durable Symptom Improvement for Patients with Non-Transfusion Dependent Thalassemia Treated with Luspatercept: Patient-Reported Outcomes from the BEYOND Study

Comparison of Alloimmunization in Pregnant People with Sickle Cell Disease Receiving Chronic Versus on-Demand Transfusions: A Multinational Study

Clocking the Processes and Challenges of Urgent Red Blood Cell Exchange for Acute Complications of Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only